ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

ORIC Pharmaceuticals (Nasdaq: ORIC) announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT.

A live webcast will be available via the company’s investor website at www.oricpharma.com, and a replay will be accessible for 90 days after the event.

Key Figures

Conference edition 44th Annual J.P. Morgan Healthcare Conference

Presentation time 9:45 a.m. PT Company overview on January 13, 2026

Webcast replay period 90 days Replay of J.P. Morgan presentation available to investors

Market Reality Check

$8.45 Last Close

Volume Volume 1,141,739 is at 0.81x the 20-day average, indicating subdued trading interest before the conference update. normal

Technical Shares at $8.15 are trading below the 200-day MA of $9.48, reflecting a weaker intermediate trend into the event.

Peers on Argus

ORIC slipped 0.24% while close biotech peers showed mixed moves (e.g., NUVB +1.06%, MAZE -2.87%, ATNF +2.92%), suggesting stock-specific trading rather than a coordinated sector move ahead of the J.P. Morgan presentation.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 05	Clinical data update	Positive	-4.4%	Phase 1b enozertinib EGFR exon 20 data with strong systemic and CNS activity.
Dec 05	Equity inducement grants	Negative	-4.4%	Inducement stock options and RSUs granted to new non-executive employees.
Dec 05	Clinical data update	Positive	-3.5%	Phase 1b enozertinib data in HER2 exon 20 NSCLC with 100% disease control rate.
Dec 04	Clinical data update	Positive	+3.8%	Enozertinib showed high ORR and intracranial activity in EGFR atypical/PACC NSCLC.
Dec 03	Conference announcement	Positive	+3.1%	Late-breaking oral presentations for enozertinib at ESMO Asia Congress 2025.

Pattern Detected

Recent clinical data for enozertinib often showed strong efficacy, yet share reactions were mixed, with some negative moves following objectively positive updates.

Recent Company History

Over the last month, ORIC highlighted multiple Phase 1b data sets for enozertinib across EGFR exon 20, EGFR atypical and HER2 exon 20 NSCLC populations, reporting high ORR, intracranial activity and manageable safety. Despite this, shares fell after several of these announcements, including the Dec 5, 2025 EGFR exon 20 and HER2 presentations. Administrative items like inducement grants also coincided with weakness. Against this backdrop, the J.P. Morgan Healthcare Conference appearance offers a platform to reiterate these developments to investors.

Market Pulse Summary

This announcement highlights ORIC’s upcoming presentation at the J.P. Morgan Healthcare Conference, with a webcast and 90-day replay providing broad access for investors. It follows multiple recent enozertinib data updates and a Q3 2025 10-Q showing substantial cash resources. Investors may focus on how management frames clinical progress, capital deployment and recent insider activity, and on any new timelines or milestones discussed during the overview.

Key Terms

oncology medical

"a clinical stage oncology company focused on developing treatments"

Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.

webcast technical

"A live webcast of the company presentation will be available"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 44^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:45 a.m. PT.

A live webcast of the company presentation will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.

About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib (ORIC-114), a brain-penetrant inhibitor targeting EGFR exon 20 and atypical mutations, being developed across multiple genetically defined cancers. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.

Contact:

Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com
info@oricpharma.com

FAQ

When will ORIC (ORIC) present at the J.P. Morgan Healthcare Conference?

ORIC will present on January 13, 2026 at 9:45 a.m. PT.

Who will present for ORIC (ORIC) at the January 13, 2026 conference?

Jacob M. Chacko, M.D., chief executive officer, will present the company overview.

How can investors watch ORIC's (ORIC) J.P. Morgan presentation live?

Watch the live webcast via the investor section of www.oricpharma.com.

Will a replay of ORIC's (ORIC) J.P. Morgan presentation be available?

Yes. A replay will be available for 90 days after the event on the company website.

What will ORIC's (ORIC) presentation cover at the J.P. Morgan Healthcare Conference?

The presentation is described as a company overview covering recent developments and strategy.